Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 190 entries
Sorted by: Best Match Show Resources per page
Fluidics of Single and Double Blade Guillotine Vitrectomy Probes in Balanced Salt Solution and Artificial Vitreous.

Translational vision science & technology

Romano MR, Stocchino A, Ferrara M, Lagazzo A, Repetto R.
PMID: 30564508
Transl Vis Sci Technol. 2018 Dec 06;7(6):19. doi: 10.1167/tvst.7.6.19. eCollection 2018 Nov.

PURPOSE: To assess the fluidics of double-vitreous cutter blade (DB) compared with single-blade (SB) guillotine with 23-, 25-, and 27-gauge vitrectomy probes. To assess flow characteristics and flow rates in viscous and viscoelastic fluids.METHODS: We used Particle Image Velocimetry...

Cite
Romano MR, Stocchino A, Ferrara M, et al. Fluidics of Single and Double Blade Guillotine Vitrectomy Probes in Balanced Salt Solution and Artificial Vitreous. Transl Vis Sci Technol. 2018;7(6):19doi: 10.1167/tvst.7.6.19.
Romano, M. R., Stocchino, A., Ferrara, M., Lagazzo, A., & Repetto, R. (2018). Fluidics of Single and Double Blade Guillotine Vitrectomy Probes in Balanced Salt Solution and Artificial Vitreous. Translational vision science & technology, 7(6), 19. https://doi.org/10.1167/tvst.7.6.19
Romano, Mario Rosario, et al. "Fluidics of Single and Double Blade Guillotine Vitrectomy Probes in Balanced Salt Solution and Artificial Vitreous." Translational vision science & technology vol. 7,6 (2018): 19. doi: https://doi.org/10.1167/tvst.7.6.19
Romano MR, Stocchino A, Ferrara M, Lagazzo A, Repetto R. Fluidics of Single and Double Blade Guillotine Vitrectomy Probes in Balanced Salt Solution and Artificial Vitreous. Transl Vis Sci Technol. 2018 Dec 06;7(6):19. doi: 10.1167/tvst.7.6.19. eCollection 2018 Nov. PMID: 30564508; PMCID: PMC6284468.
Copy Download .nbib Format: NLM
Polymorphism in Toll-Like Receptors and .

Cancers

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.
PMID: 31083432
Cancers (Basel). 2019 May 10;11(5). doi: 10.3390/cancers11050648.

Autoimmune atrophic gastritis (AAG) is associated with an increased risk of certain types of gastric cancer (GC).

Cite
De Re V, Repetto O, De Zorzi M, et al. Polymorphism in Toll-Like Receptors and . Cancers (Basel). 2019;11(5)doi: 10.3390/cancers11050648.
De Re, V., Repetto, O., De Zorzi, M., Casarotto, M., Tedeschi, M., Giuffrida, P., Lenti, M. V., Magris, R., Miolo, G., Mazzon, C., Zanette, G., Alessandrini, L., Canzonieri, V., Caggiari, L., Zanussi, S., Steffan, A., Di Sabatino, A., & Cannizzaro, R. (2019). Polymorphism in Toll-Like Receptors and . Cancers, 11(5), . https://doi.org/10.3390/cancers11050648
De Re, Valli, et al. "Polymorphism in Toll-Like Receptors and ." Cancers vol. 11,5 (2019). doi: https://doi.org/10.3390/cancers11050648
De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R. Polymorphism in Toll-Like Receptors and . Cancers (Basel). 2019 May 10;11(5). doi: 10.3390/cancers11050648. PMID: 31083432; PMCID: PMC6562993.
Copy Download .nbib Format: NLM
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.

Molecular psychiatry

Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, Warren ST, Owen MJ, Chopra P, Cutler DJ, Duncan R, Kotlar AV, Mulle JG, Voss AJ, Zwick ME, Diacou A, Golden A, Guo T, Lin JR, Wang T, Zhang Z, Zhao Y, Marshall C, Merico D, Jin A, Lilley B, Salmons HI, Tran O, Holmans P, Pardinas A, Walters JTR, Demaerel W, Boot E, Butcher NJ, Costain GA, Lowther C, Evers R, van Amelsvoort TAMJ, van Duin E, Vingerhoets C, Breckpot J, Devriendt K, Vergaelen E, Vogels A, Crowley TB, McGinn DE, Moss EM, Sharkus RJ, Unolt M, Zackai EH, Calkins ME, Gallagher RS, Gur RC, Tang SX, Fritsch R, Ornstein C, Repetto GM, Breetvelt E, Duijff SN, Fiksinski A, Moss H, Niarchou M, Murphy KC, Prasad SE, Daly EM, Gudbrandsen M, Murphy CM, Murphy DG, Buzzanca A, Fabio FD, Digilio MC, Pontillo M, Marino B, Vicari S, Coleman K, Cubells JF, Ousley OY, Carmel M, Gothelf D, Mekori-Domachevsky E, Michaelovsky E, Weinberger R, Weizman A, Kushan L, Jalbrzikowski M, Armando M, Eliez S, Sandini C, Schneider M, Béna FS, Antshel KM, Fremont W, Kates WR, Belzeaux R, Busa T, Philip N, Campbell LE, McCabe KL, Hooper SR, Schoch K, Shashi V, Simon TJ, Tassone F, Arango C, Fraguas D, García-Miñaúr S, Morey-Canyelles J, Rosell J, Suñer DH, Raventos-Simic J, Epstein MP, Williams NM, Bassett AS.
PMID: 32015465
Mol Psychiatry. 2021 Aug;26(8):4496-4510. doi: 10.1038/s41380-020-0654-3. Epub 2020 Feb 03.

Schizophrenia occurs in about one in four individuals with 22q11.2 deletion syndrome (22q11.2DS). The aim of this International Brain and Behavior 22q11.2DS Consortium (IBBC) study was to identify genetic factors that contribute to schizophrenia, in addition to the ~20-fold...

Cite
Cleynen I, Engchuan W, Hestand MS, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry. 2020;26(8):4496-4510doi: 10.1038/s41380-020-0654-3.
Cleynen, I., Engchuan, W., Hestand, M. S., Heung, T., Holleman, A. M., Johnston, H. R., Monfeuga, T., McDonald-McGinn, D. M., Gur, R. E., Morrow, B. E., Swillen, A., Vorstman, J. A. S., Bearden, C. E., Chow, E. W. C., van den Bree, M., Emanuel, B. S., Vermeesch, J. R., Warren, S. T., Owen, M. J., Chopra, P., Cutler, D. J., Duncan, R., Kotlar, A. V., Mulle, J. G., Voss, A. J., Zwick, M. E., Diacou, A., Golden, A., Guo, T., Lin, J. R., Wang, T., Zhang, Z., Zhao, Y., Marshall, C., Merico, D., Jin, A., Lilley, B., Salmons, H. I., Tran, O., Holmans, P., Pardinas, A., Walters, J. T. R., Demaerel, W., Boot, E., Butcher, N. J., Costain, G. A., Lowther, C., Evers, R., van Amelsvoort, T. A. M. J., van Duin, E., Vingerhoets, C., Breckpot, J., Devriendt, K., Vergaelen, E., Vogels, A., Crowley, T. B., McGinn, D. E., Moss, E. M., Sharkus, R. J., Unolt, M., Zackai, E. H., Calkins, M. E., Gallagher, R. S., Gur, R. C., Tang, S. X., Fritsch, R., Ornstein, C., Repetto, G. M., Breetvelt, E., Duijff, S. N., Fiksinski, A., Moss, H., Niarchou, M., Murphy, K. C., Prasad, S. E., Daly, E. M., Gudbrandsen, M., Murphy, C. M., Murphy, D. G., Buzzanca, A., Fabio, F. D., Digilio, M. C., Pontillo, M., Marino, B., Vicari, S., Coleman, K., Cubells, J. F., Ousley, O. Y., Carmel, M., Gothelf, D., Mekori-Domachevsky, E., Michaelovsky, E., Weinberger, R., Weizman, A., Kushan, L., Jalbrzikowski, M., Armando, M., Eliez, S., Sandini, C., Schneider, M., Béna, F. S., Antshel, K. M., Fremont, W., Kates, W. R., Belzeaux, R., Busa, T., Philip, N., Campbell, L. E., McCabe, K. L., Hooper, S. R., Schoch, K., Shashi, V., Simon, T. J., Tassone, F., Arango, C., Fraguas, D., García-Miñaúr, S., Morey-Canyelles, J., Rosell, J., Suñer, D. H., Raventos-Simic, J., Epstein, M. P., Williams, N. M., & Bassett, A. S. (2021). Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Molecular psychiatry, 26(8), 4496-4510. https://doi.org/10.1038/s41380-020-0654-3
Cleynen, Isabelle, et al. "Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion." Molecular psychiatry vol. 26,8 (2021): 4496-4510. doi: https://doi.org/10.1038/s41380-020-0654-3
Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, Warren ST, Owen MJ, Chopra P, Cutler DJ, Duncan R, Kotlar AV, Mulle JG, Voss AJ, Zwick ME, Diacou A, Golden A, Guo T, Lin JR, Wang T, Zhang Z, Zhao Y, Marshall C, Merico D, Jin A, Lilley B, Salmons HI, Tran O, Holmans P, Pardinas A, Walters JTR, Demaerel W, Boot E, Butcher NJ, Costain GA, Lowther C, Evers R, van Amelsvoort TAMJ, van Duin E, Vingerhoets C, Breckpot J, Devriendt K, Vergaelen E, Vogels A, Crowley TB, McGinn DE, Moss EM, Sharkus RJ, Unolt M, Zackai EH, Calkins ME, Gallagher RS, Gur RC, Tang SX, Fritsch R, Ornstein C, Repetto GM, Breetvelt E, Duijff SN, Fiksinski A, Moss H, Niarchou M, Murphy KC, Prasad SE, Daly EM, Gudbrandsen M, Murphy CM, Murphy DG, Buzzanca A, Fabio FD, Digilio MC, Pontillo M, Marino B, Vicari S, Coleman K, Cubells JF, Ousley OY, Carmel M, Gothelf D, Mekori-Domachevsky E, Michaelovsky E, Weinberger R, Weizman A, Kushan L, Jalbrzikowski M, Armando M, Eliez S, Sandini C, Schneider M, Béna FS, Antshel KM, Fremont W, Kates WR, Belzeaux R, Busa T, Philip N, Campbell LE, McCabe KL, Hooper SR, Schoch K, Shashi V, Simon TJ, Tassone F, Arango C, Fraguas D, García-Miñaúr S, Morey-Canyelles J, Rosell J, Suñer DH, Raventos-Simic J, Epstein MP, Williams NM, Bassett AS. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry. 2021 Aug;26(8):4496-4510. doi: 10.1038/s41380-020-0654-3. Epub 2020 Feb 03. PMID: 32015465; PMCID: PMC7396297.
Copy Download .nbib Format: NLM
Customized Application of tDCS for Clinical Rehabilitation in Alzheimer's Disease.

Frontiers in human neuroscience

Rodella C, Cespón J, Repetto C, Pellicciari MC.
PMID: 34393740
Front Hum Neurosci. 2021 Jul 29;15:687968. doi: 10.3389/fnhum.2021.687968. eCollection 2021.

No abstract available.

Cite
Rodella C, Cespón J, Repetto C, et al. Customized Application of tDCS for Clinical Rehabilitation in Alzheimer's Disease. Front Hum Neurosci. 2021;15:687968doi: 10.3389/fnhum.2021.687968.
Rodella, C., Cespón, J., Repetto, C., & Pellicciari, M. C. (2021). Customized Application of tDCS for Clinical Rehabilitation in Alzheimer's Disease. Frontiers in human neuroscience, 15687968. https://doi.org/10.3389/fnhum.2021.687968
Rodella, Claudia, et al. "Customized Application of tDCS for Clinical Rehabilitation in Alzheimer's Disease." Frontiers in human neuroscience vol. 15 (2021): 687968. doi: https://doi.org/10.3389/fnhum.2021.687968
Rodella C, Cespón J, Repetto C, Pellicciari MC. Customized Application of tDCS for Clinical Rehabilitation in Alzheimer's Disease. Front Hum Neurosci. 2021 Jul 29;15:687968. doi: 10.3389/fnhum.2021.687968. eCollection 2021. PMID: 34393740; PMCID: PMC8358653.
Copy Download .nbib Format: NLM
Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs.

Human brain mapping

Sønderby IE, Ching CRK, Thomopoulos SI, van der Meer D, Sun D, Villalon-Reina JE, Agartz I, Amunts K, Arango C, Armstrong NJ, Ayesa-Arriola R, Bakker G, Bassett AS, Boomsma DI, Bülow R, Butcher NJ, Calhoun VD, Caspers S, Chow EWC, Cichon S, Ciufolini S, Craig MC, Crespo-Facorro B, Cunningham AC, Dale AM, Dazzan P, de Zubicaray GI, Djurovic S, Doherty JL, Donohoe G, Draganski B, Durdle CA, Ehrlich S, Emanuel BS, Espeseth T, Fisher SE, Ge T, Glahn DC, Grabe HJ, Gur RE, Gutman BA, Haavik J, Håberg AK, Hansen LA, Hashimoto R, Hibar DP, Holmes AJ, Hottenga JJ, Hulshoff Pol HE, Jalbrzikowski M, Knowles EEM, Kushan L, Linden DEJ, Liu J, Lundervold AJ, Martin-Brevet S, Martínez K, Mather KA, Mathias SR, McDonald-McGinn DM, McRae AF, Medland SE, Moberget T, Modenato C, Monereo Sánchez J, Moreau CA, Mühleisen TW, Paus T, Pausova Z, Prieto C, Ragothaman A, Reinbold CS, Reis Marques T, Repetto GM, Reymond A, Roalf DR, Rodriguez-Herreros B, Rucker JJ, Sachdev PS, Schmitt JE, Schofield PR, Silva AI, Stefansson H, Stein DJ, Tamnes CK, Tordesillas-Gutiérrez D, Ulfarsson MO, Vajdi A, van 't Ent D, van den Bree MBM, Vassos E, Vázquez-Bourgon J, Vila-Rodriguez F, Walters GB, Wen W, Westlye LT, Wittfeld K, Zackai EH, Stefánsson K, Jacquemont S, Thompson PM, Bearden CE, Andreassen OA.
PMID: 33615640
Hum Brain Mapp. 2022 Jan;43(1):300-328. doi: 10.1002/hbm.25354. Epub 2021 Feb 21.

The Enhancing NeuroImaging Genetics through Meta-Analysis copy number variant (ENIGMA-CNV) and 22q11.2 Deletion Syndrome Working Groups (22q-ENIGMA WGs) were created to gain insight into the involvement of genetic factors in human brain development and related cognitive, psychiatric and behavioral...

Cite
Sønderby IE, Ching CRK, Thomopoulos SI, et al. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs. Hum Brain Mapp. 2021;43(1):300-328doi: 10.1002/hbm.25354.
Sønderby, I. E., Ching, C. R. K., Thomopoulos, S. I., van der Meer, D., Sun, D., Villalon-Reina, J. E., Agartz, I., Amunts, K., Arango, C., Armstrong, N. J., Ayesa-Arriola, R., Bakker, G., Bassett, A. S., Boomsma, D. I., Bülow, R., Butcher, N. J., Calhoun, V. D., Caspers, S., Chow, E. W. C., Cichon, S., Ciufolini, S., Craig, M. C., Crespo-Facorro, B., Cunningham, A. C., Dale, A. M., Dazzan, P., de Zubicaray, G. I., Djurovic, S., Doherty, J. L., Donohoe, G., Draganski, B., Durdle, C. A., Ehrlich, S., Emanuel, B. S., Espeseth, T., Fisher, S. E., Ge, T., Glahn, D. C., Grabe, H. J., Gur, R. E., Gutman, B. A., Haavik, J., Håberg, A. K., Hansen, L. A., Hashimoto, R., Hibar, D. P., Holmes, A. J., Hottenga, J. J., Hulshoff Pol, H. E., Jalbrzikowski, M., Knowles, E. E. M., Kushan, L., Linden, D. E. J., Liu, J., Lundervold, A. J., Martin-Brevet, S., Martínez, K., Mather, K. A., Mathias, S. R., McDonald-McGinn, D. M., McRae, A. F., Medland, S. E., Moberget, T., Modenato, C., Monereo Sánchez, J., Moreau, C. A., Mühleisen, T. W., Paus, T., Pausova, Z., Prieto, C., Ragothaman, A., Reinbold, C. S., Reis Marques, T., Repetto, G. M., Reymond, A., Roalf, D. R., Rodriguez-Herreros, B., Rucker, J. J., Sachdev, P. S., Schmitt, J. E., Schofield, P. R., Silva, A. I., Stefansson, H., Stein, D. J., Tamnes, C. K., Tordesillas-Gutiérrez, D., Ulfarsson, M. O., Vajdi, A., van 't Ent, D., van den Bree, M. B. M., Vassos, E., Vázquez-Bourgon, J., Vila-Rodriguez, F., Walters, G. B., Wen, W., Westlye, L. T., Wittfeld, K., Zackai, E. H., Stefánsson, K., Jacquemont, S., Thompson, P. M., Bearden, C. E., Andreassen, O. A. (2022). Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs. Human brain mapping, 43(1), 300-328. https://doi.org/10.1002/hbm.25354
Sønderby, Ida E, et al. "Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs." Human brain mapping vol. 43,1 (2022): 300-328. doi: https://doi.org/10.1002/hbm.25354
Sønderby IE, Ching CRK, Thomopoulos SI, van der Meer D, Sun D, Villalon-Reina JE, Agartz I, Amunts K, Arango C, Armstrong NJ, Ayesa-Arriola R, Bakker G, Bassett AS, Boomsma DI, Bülow R, Butcher NJ, Calhoun VD, Caspers S, Chow EWC, Cichon S, Ciufolini S, Craig MC, Crespo-Facorro B, Cunningham AC, Dale AM, Dazzan P, de Zubicaray GI, Djurovic S, Doherty JL, Donohoe G, Draganski B, Durdle CA, Ehrlich S, Emanuel BS, Espeseth T, Fisher SE, Ge T, Glahn DC, Grabe HJ, Gur RE, Gutman BA, Haavik J, Håberg AK, Hansen LA, Hashimoto R, Hibar DP, Holmes AJ, Hottenga JJ, Hulshoff Pol HE, Jalbrzikowski M, Knowles EEM, Kushan L, Linden DEJ, Liu J, Lundervold AJ, Martin-Brevet S, Martínez K, Mather KA, Mathias SR, McDonald-McGinn DM, McRae AF, Medland SE, Moberget T, Modenato C, Monereo Sánchez J, Moreau CA, Mühleisen TW, Paus T, Pausova Z, Prieto C, Ragothaman A, Reinbold CS, Reis Marques T, Repetto GM, Reymond A, Roalf DR, Rodriguez-Herreros B, Rucker JJ, Sachdev PS, Schmitt JE, Schofield PR, Silva AI, Stefansson H, Stein DJ, Tamnes CK, Tordesillas-Gutiérrez D, Ulfarsson MO, Vajdi A, van 't Ent D, van den Bree MBM, Vassos E, Vázquez-Bourgon J, Vila-Rodriguez F, Walters GB, Wen W, Westlye LT, Wittfeld K, Zackai EH, Stefánsson K, Jacquemont S, Thompson PM, Bearden CE, Andreassen OA. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs. Hum Brain Mapp. 2022 Jan;43(1):300-328. doi: 10.1002/hbm.25354. Epub 2021 Feb 21. PMID: 33615640.
Copy Download .nbib Format: NLM
Possible clinical failure of artemether-lumefantrine in an italian traveler with uncomplicated falciparum malaria.

Mediterranean journal of hematology and infectious diseases

Repetto EC, Traverso A, Giacomazzi CG.
PMID: 22084655
Mediterr J Hematol Infect Dis. 2011;3(1):e2011041. doi: 10.4084/MJHID.2011.041. Epub 2011 Oct 01.

Artemisinin-combination therapies (ACTs) are recommended for the treatment of uncomplicated malaria in endemic areas with multidrug resistant Plasmodium falciparum. We report a case of possible artemether-lumefantrine clinical failure in an Italian traveler with uncomplicated P. falciparum malaria imported from...

Cite
Repetto EC, Traverso A, Giacomazzi CG. Possible clinical failure of artemether-lumefantrine in an italian traveler with uncomplicated falciparum malaria. Mediterr J Hematol Infect Dis. 2011;3(1):e2011041doi: 10.4084/MJHID.2011.041.
Repetto, E. C., Traverso, A., & Giacomazzi, C. G. (2011). Possible clinical failure of artemether-lumefantrine in an italian traveler with uncomplicated falciparum malaria. Mediterranean journal of hematology and infectious diseases, 3(1), e2011041. https://doi.org/10.4084/MJHID.2011.041
Repetto, Ernestina C, et al. "Possible clinical failure of artemether-lumefantrine in an italian traveler with uncomplicated falciparum malaria." Mediterranean journal of hematology and infectious diseases vol. 3,1 (2011): e2011041. doi: https://doi.org/10.4084/MJHID.2011.041
Repetto EC, Traverso A, Giacomazzi CG. Possible clinical failure of artemether-lumefantrine in an italian traveler with uncomplicated falciparum malaria. Mediterr J Hematol Infect Dis. 2011;3(1):e2011041. doi: 10.4084/MJHID.2011.041. Epub 2011 Oct 01. PMID: 22084655; PMCID: PMC3212973.
Copy Download .nbib Format: NLM
Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics.

Small (Weinheim an der Bergstrasse, Germany)

Boloix A, Feiner-Gracia N, Köber M, Repetto J, Pascarella R, Soriano A, Masanas M, Segovia N, Vargas-Nadal G, Merlo-Mas J, Danino D, Abutbul-Ionita I, Foradada L, Roma J, Córdoba A, Sala S, de Toledo JS, Gallego S, Veciana J, Albertazzi L, Segura MF, Ventosa N.
PMID: 34786859
Small. 2021 Nov 16;e2101959. doi: 10.1002/smll.202101959. Epub 2021 Nov 16.

MicroRNAs (miRNAs) are small non-coding endogenous RNAs, which are attracting a growing interest as therapeutic molecules due to their central role in major diseases. However, the transformation of these biomolecules into drugs is limited due to their unstability in...

Cite
Boloix A, Feiner-Gracia N, Köber M, et al. Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics. Small. 2021;e2101959doi: 10.1002/smll.202101959.
Boloix, A., Feiner-Gracia, N., Köber, M., Repetto, J., Pascarella, R., Soriano, A., Masanas, M., Segovia, N., Vargas-Nadal, G., Merlo-Mas, J., Danino, D., Abutbul-Ionita, I., Foradada, L., Roma, J., Córdoba, A., Sala, S., de Toledo, J. S., Gallego, S., Veciana, J., Albertazzi, L., Segura, M. F., & Ventosa, N. (2021). Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics. Small (Weinheim an der Bergstrasse, Germany), e2101959. https://doi.org/10.1002/smll.202101959
Boloix, Ariadna, et al. "Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics." Small (Weinheim an der Bergstrasse, Germany) vol. (2021): e2101959. doi: https://doi.org/10.1002/smll.202101959
Boloix A, Feiner-Gracia N, Köber M, Repetto J, Pascarella R, Soriano A, Masanas M, Segovia N, Vargas-Nadal G, Merlo-Mas J, Danino D, Abutbul-Ionita I, Foradada L, Roma J, Córdoba A, Sala S, de Toledo JS, Gallego S, Veciana J, Albertazzi L, Segura MF, Ventosa N. Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics. Small. 2021 Nov 16;e2101959. doi: 10.1002/smll.202101959. Epub 2021 Nov 16. PMID: 34786859.
Copy Download .nbib Format: NLM
The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods.

Methods in molecular biology (Clifton, N.J.)

Bregenzer M, Horst E, Mehta P, Snyder C, Repetto T, Mehta G.
PMID: 34918298
Methods Mol Biol. 2022;2424:217-245. doi: 10.1007/978-1-0716-1956-8_15.

Cancer stem-like cells (CSC) are responsible for tumor progression, chemoresistance, recurrence, and poor outcomes in many cancers, making them critical research and therapeutic targets. One of the critical components potentiating CSC chemoresistance is the interactions between CSC and the...

Cite
Bregenzer M, Horst E, Mehta P, et al. The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods. Methods Mol Biol. 2022;2424:217-245doi: 10.1007/978-1-0716-1956-8_15.
Bregenzer, M., Horst, E., Mehta, P., Snyder, C., Repetto, T., & Mehta, G. (2022). The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods. Methods in molecular biology (Clifton, N.J.), 2424217-245. https://doi.org/10.1007/978-1-0716-1956-8_15
Bregenzer, Michael, et al. "The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods." Methods in molecular biology (Clifton, N.J.) vol. 2424 (2022): 217-245. doi: https://doi.org/10.1007/978-1-0716-1956-8_15
Bregenzer M, Horst E, Mehta P, Snyder C, Repetto T, Mehta G. The Role of the Tumor Microenvironment in CSC Enrichment and Chemoresistance: 3D Co-culture Methods. Methods Mol Biol. 2022;2424:217-245. doi: 10.1007/978-1-0716-1956-8_15. PMID: 34918298.
Copy Download .nbib Format: NLM
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Journal of cardiovascular medicine (Hagerstown, Md.)

Ferlini M, Leonardi S, Mandurino Mirizzi A, Montalto C, Crimi G, Repetto A, Marinoni B, Somaschini A, Ferrario M, Klersy C, Oltrona Visconti L.
PMID: 34076601
J Cardiovasc Med (Hagerstown). 2021 Jul 01;22(7):539-545. doi: 10.2459/JCM.0000000000001174.

AIM: To compare the pharmacodynamic effect of an oral loading dose of 'noncoated' ASA 300 mg vs. an intravenous bolus injection of lysine acetylsalicylate 150 mg in patients with STEMI undergoing pPCI.METHODS: This was a prospective single-center, open label,...

Cite
Ferlini M, Leonardi S, Mandurino Mirizzi A, et al. Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Cardiovasc Med (Hagerstown). 2021;22(7):539-545doi: 10.2459/JCM.0000000000001174.
Ferlini, M., Leonardi, S., Mandurino Mirizzi, A., Montalto, C., Crimi, G., Repetto, A., Marinoni, B., Somaschini, A., Ferrario, M., Klersy, C., & Oltrona Visconti, L. (2021). Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Journal of cardiovascular medicine (Hagerstown, Md.), 22(7), 539-545. https://doi.org/10.2459/JCM.0000000000001174
Ferlini, Marco, et al. "Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention." Journal of cardiovascular medicine (Hagerstown, Md.) vol. 22,7 (2021): 539-545. doi: https://doi.org/10.2459/JCM.0000000000001174
Ferlini M, Leonardi S, Mandurino Mirizzi A, Montalto C, Crimi G, Repetto A, Marinoni B, Somaschini A, Ferrario M, Klersy C, Oltrona Visconti L. Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Cardiovasc Med (Hagerstown). 2021 Jul 01;22(7):539-545. doi: 10.2459/JCM.0000000000001174. PMID: 34076601.
Copy Download .nbib Format: NLM
Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners.

Frontiers in pharmacology

Undurraga J, Bórquez-Infante I, Crossley NA, Prieto ML, Repetto GM.
PMID: 33935777
Front Pharmacol. 2021 Apr 15;12:657985. doi: 10.3389/fphar.2021.657985. eCollection 2021.

Use of pharmacogenetics (PGx) testing to guide clinical decisions is growing in developed countries. Published guidelines for gene-drug pair analysis are available for prescriptions in psychiatry, but information on their utilization, barriers, and health outcomes in Latin America is...

Cite
Undurraga J, Bórquez-Infante I, Crossley NA, et al. Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners. Front Pharmacol. 2021;12:657985doi: 10.3389/fphar.2021.657985.
Undurraga, J., Bórquez-Infante, I., Crossley, N. A., Prieto, M. L., & Repetto, G. M. (2021). Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners. Frontiers in pharmacology, 12657985. https://doi.org/10.3389/fphar.2021.657985
Undurraga, Juan, et al. "Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners." Frontiers in pharmacology vol. 12 (2021): 657985. doi: https://doi.org/10.3389/fphar.2021.657985
Undurraga J, Bórquez-Infante I, Crossley NA, Prieto ML, Repetto GM. Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners. Front Pharmacol. 2021 Apr 15;12:657985. doi: 10.3389/fphar.2021.657985. eCollection 2021. PMID: 33935777; PMCID: PMC8082421.
Copy Download .nbib Format: NLM
La tétherine, dernière amarre du VIH.

Virologie (Montrouge, France)

Aschman N, Weissenhorn W, Renesto P.
PMID: 33065886
Virologie (Montrouge). 2012 Feb 01;16(1):32-42. doi: 10.1684/vir.2012.0430.

Tetherin is an unusual surface glycoprotein that employs an N-terminal and a C-terminal region to anchor the protein into membranes. Structural analyses revealed an elongated structure for the ectodomain that is probably oriented parallel to cellular membranes. Expression of...

Cite
Aschman N, Weissenhorn W, Renesto P. La tétherine, dernière amarre du VIH. La tétherine, dernière amarre du VIH. Virologie (Montrouge). 2012;16(1):32-42doi: 10.1684/vir.2012.0430.
Aschman, N., Weissenhorn, W., & Renesto, P. (2012). La tétherine, dernière amarre du VIH. La tétherine, dernière amarre du VIH. Virologie (Montrouge, France), 16(1), 32-42. https://doi.org/10.1684/vir.2012.0430
Aschman, Nicolas, et al. "La tétherine, dernière amarre du VIH." La tétherine, dernière amarre du VIH. Virologie (Montrouge, France) vol. 16,1 (2012): 32-42. doi: https://doi.org/10.1684/vir.2012.0430
Aschman N, Weissenhorn W, Renesto P. La tétherine, dernière amarre du VIH. La tétherine, dernière amarre du VIH. Virologie (Montrouge). 2012 Feb 01;16(1):32-42. doi: 10.1684/vir.2012.0430. PMID: 33065886.
Copy Download .nbib Format: NLM
Mapping the serum proteome to neurological diseases using whole genome sequencing.

Nature communications

Png G, Barysenka A, Repetto L, Navarro P, Shen X, Pietzner M, Wheeler E, Wareham NJ, Langenberg C, Tsafantakis E, Karaleftheri M, Dedoussis G, Mälarstig A, Wilson JF, Gilly A, Zeggini E.
PMID: 34857772
Nat Commun. 2021 Dec 02;12(1):7042. doi: 10.1038/s41467-021-27387-1.

Despite the increasing global burden of neurological disorders, there is a lack of effective diagnostic and therapeutic biomarkers. Proteins are often dysregulated in disease and have a strong genetic component. Here, we carry out a protein quantitative trait locus...

Cite
Png G, Barysenka A, Repetto L, et al. Mapping the serum proteome to neurological diseases using whole genome sequencing. Nat Commun. 2021;12(1):7042doi: 10.1038/s41467-021-27387-1.
Png, G., Barysenka, A., Repetto, L., Navarro, P., Shen, X., Pietzner, M., Wheeler, E., Wareham, N. J., Langenberg, C., Tsafantakis, E., Karaleftheri, M., Dedoussis, G., Mälarstig, A., Wilson, J. F., Gilly, A., & Zeggini, E. (2021). Mapping the serum proteome to neurological diseases using whole genome sequencing. Nature communications, 12(1), 7042. https://doi.org/10.1038/s41467-021-27387-1
Png, Grace, et al. "Mapping the serum proteome to neurological diseases using whole genome sequencing." Nature communications vol. 12,1 (2021): 7042. doi: https://doi.org/10.1038/s41467-021-27387-1
Png G, Barysenka A, Repetto L, Navarro P, Shen X, Pietzner M, Wheeler E, Wareham NJ, Langenberg C, Tsafantakis E, Karaleftheri M, Dedoussis G, Mälarstig A, Wilson JF, Gilly A, Zeggini E. Mapping the serum proteome to neurological diseases using whole genome sequencing. Nat Commun. 2021 Dec 02;12(1):7042. doi: 10.1038/s41467-021-27387-1. PMID: 34857772; PMCID: PMC8640022.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 190 entries